Datroway (datopotamab deruxtecan)

Datroway (datopotamab deruxtecan)

Datroway

Datopotamab deruxtecan

Single dose Vial- 100 mg

Daiichi Sankyo

Medical Use

Medical Uses – DATROWAY is a Trop-2-directed antibody and topoisomerase inhibitor conjugate indicated for the treatment of adult patients with unresectable or metastatic, hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative (IHC 0, IHC 1+ or IHC 2+/ISH-) breast cancer who have received prior endocrine-based therapy and chemotherapy for unresectable or metastatic disease.

WhatsApp Chat